Literature DB >> 16205748

How to judge a tumor marker.

Ethan M Katz1, Michael W Kattan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16205748     DOI： 10.1038/ncponc0318

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN： 1743-4254


× No keyword cloud information.
  6 in total

Review 1.  Role of nomograms for prostate cancer in 2007.

Authors:  Felix K-H Chun; Pierre I Karakiewicz; Hartwig Huland; Markus Graefen
Journal:  World J Urol       Date:  2007-02-27       Impact factor: 4.226

2.  New Prognostic Markers: The Pathway from Research to Clinical Practice.

Authors:  Caroline Savage; Andrew J Vickers
Journal:  Grand rounds Urol       Date:  2009-08

3.  Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.

Authors:  Danil V Makarov; Cameron Marlow; Jonathan I Epstein; M Craig Miller; Patricia Landis; Alan W Partin; H Ballentine Carter; Robert W Veltri
Journal:  Prostate       Date:  2008-02-01       Impact factor: 4.104

4.  An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer.

Authors:  Ralph R Weichselbaum; Hemant Ishwaran; Taewon Yoon; Dimitry S A Nuyten; Samuel W Baker; Nikolai Khodarev; Andy W Su; Arif Y Shaikh; Paul Roach; Bas Kreike; Bernard Roizman; Jonas Bergh; Yudi Pawitan; Marc J van de Vijver; Andy J Minn
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-10       Impact factor: 11.205

5.  Development and validation of a prognostic gene-expression signature for lung adenocarcinoma.

Authors:  Yun-Yong Park; Eun Sung Park; Sang Bae Kim; Sang Cheol Kim; Bo Hwa Sohn; In-Sun Chu; Woojin Jeong; Gordon B Mills; Lauren Averett Byers; Ju-Seog Lee
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

Review 6.  Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.

Authors:  R D Riley; W Sauerbrei; D G Altman
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.